Legal Representation
Attorney
Peter C. Stomma
USPTO Deadlines
Next Deadline
2183 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 06, 2032
Grace Period Ends
July 06, 2032
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 6, 2026 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 6, 2026 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 15, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 23, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 30, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 30, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 30, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 6, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 6, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 6, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 31, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 045
Providing resources to create and license intellectual property to companies to advance suitable drugs for further development and to facilitate research and development of drug candidates
First Use Anywhere:
Nov 30, 2020
First Use in Commerce:
Nov 30, 2020
Classification
International Classes
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"